Major Advances in the Treatment of Cancer What does a Non-Oncologist need to know? Journal title: Sultan Qaboos University Medical Journal Authors: Ikram A Burney| Department of Medicine, Sultan Qaboos University, Muscat, Oman, Mansour S Al-Moundhr... Subject(s): Medicine, Biochemistry, Biomedicine
UV spectrophotometric estimation of sorafenib in pure and tablet dosage form Journal title: Journal of Pharmacy Research Authors: Rama l i n g am Ka l a i c h e l v i 1 * and Ekambaram Jayachandran 2 Subject(s):
HPTLC DETERMINATION OF SORAFENIB TOSYLATE IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORM Journal title: International Research Journal of Pharmacy (IRJP) Authors: Amol Powar , Pramila Gowda Subject(s):
Sorafenib in renal cell carcinoma Journal title: Pakistan Journal of Pharmaceutical Sciences Authors: Ehsan Taghizadeh Davoudi , Mohamed Ibrahim bin Noordin , Hamid Akbari Javar , Ali Kadivar , Bahare S... Subject(s):
Stevens - Johnson Syndrome Induced by Sorafenib for Hepatocellular Carcinoma Journal title: International Journal of Clinical Dermatology & Research (IJCDR) Authors: Chakiri Radia Subject(s):
Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma Journal title: Journal of Cancer and Tumor International Authors: Yasser M. Saleh, Waleed Hammam Subject(s):
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Journal title: Annals of Hepatology Authors: Marco Biolato, Giulia Gallusi, Massimo Iavarone, Giuseppe Cabibbo, Simona Racco, Adriano De Santis,... Subject(s):
QSAR Modeling useful in Anti-Cancer Drug Discovery: Prediction of V600EBRAF-Dependent P-ERK using Monte Carlo Method Journal title: Journal of Gynecology and Neonatal Biology Authors: Khalid Bouhedjar Subject(s):
Lenvatinib Suppresses Angiogenesis through the Inhibition of both the VEGFR and FGFR Signaling Pathways Journal title: Global Journal of Cancer Therapy Authors: Ichikawa Kenji, Miyano Saori Watanabe, Adachi Yusuke, Matsuki Masahiro, Okamoto Kiyoshi, Matsui Junj... Subject(s):
Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation Journal title: National Journal of Physiology, Pharmacy and Pharmacology Authors: Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Anila K N Subject(s):
Skin Hypopigmentation in a Patient with Papillary Carcinoma Thyroid Treated with Sorafenib Journal title: Cancer Studies & Molecular Medicine – Open Journal Authors: Keechilat Pavithran Subject(s):
Advanced Hepatocellular Carcinoma in A Scottish Population – Current Experience and the Future Journal title: Current Trends in Gastroenterology and Hepatology Authors: Baxter MA, Peters AL, Graham J Subject(s):
Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization Journal title: Biomedical Journal of Scientific & Technical Research (BJSTR) Authors: Tadaaki Arizumic, Tomohiro Minami, Masatoshi Kudo Subject(s):
Effect of sorafenib in a murine high risk penetrating keratoplasty model Journal title: International Journal of Ophthalmology Authors: Yang Kyung Cho Subject(s):
ANTI-PARKINSON’S ACTIVITY OF SORAFENIB IN 6-OHDA INDUCED RAT MODEL Journal title: International Journal of Pharmaceutical Sciences and Research (IJPSR) Authors: R. Vadivelan et al. Subject(s):
